Growth Metrics

Vertex Pharmaceuticals (VRTX) Revenue (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.37%
Dec 31, 2025 3.69%
Sep 30, 2025 3.77%
Jun 30, 2025 7.02%
Mar 31, 2025 -4.87%
Dec 31, 2024 5.05%
Sep 30, 2024 4.77%
Jun 30, 2024 -1.67%
Mar 31, 2024 6.87%
Dec 31, 2023 1.38%
Sep 30, 2023 -0.39%
Jun 30, 2023 4.99%
Mar 31, 2023 3.13%
Dec 31, 2022 -1.35%
Sep 30, 2022 6.29%
Jun 30, 2022 4.71%
Mar 31, 2022 1.20%
Dec 31, 2021 4.46%
Sep 30, 2021 10.63%
Jun 30, 2021 4.01%
Mar 31, 2021 5.93%
Dec 31, 2020 5.82%
Sep 30, 2020 0.90%
Jun 30, 2020 0.62%
Mar 31, 2020 872.47%
Dec 31, 2019 -83.60%
Sep 30, 2019 0.91%
Jun 30, 2019 9.65%
Mar 31, 2019 -1.34%
Dec 31, 2018 10.91%
Sep 30, 2018 4.30%
Jun 30, 2018 17.38%
Mar 31, 2018 -1.66%
Dec 31, 2017 12.71%
Sep 30, 2017 6.25%
Jun 30, 2017 -23.87%
Mar 31, 2017 55.81%
Dec 31, 2016 11.96%
Sep 30, 2016 -3.75%
Jun 30, 2016 6.93%
Mar 31, 2016 -2.08%
Dec 31, 2015 34.39%
Sep 30, 2015 82.15%
Jun 30, 2015 26.90%
Mar 31, 2015 -9.46%
Dec 31, 2014 5.44%
Sep 30, 2014 12.08%
Jun 30, 2014 3.27%
Mar 31, 2014 -8.05%
Dec 31, 2013 -41.89%
Sep 30, 2013 -12.99%
Jun 30, 2013 -22.41%
Mar 31, 2013 -1.68%
Dec 31, 2012 -0.60%
Sep 30, 2012 -19.67%
Jun 30, 2012 11.44%
Mar 31, 2012 -33.37%
Dec 31, 2011 34.26%
Mar 31, 2011 12.42%
Dec 31, 2010 175.37%
Sep 30, 2010 -24.75%
Jun 30, 2010 40.99%
Mar 31, 2010 -33.82%
Dec 31, 2009 35.79%
Sep 30, 2009 30.91%
Jun 30, 2009 -20.50%